ISIN : DE000BAY0017 - Telekurs : 324230 - Bloomberg : BAYN GY - Reuters : BAYGn.DE


Settore: Salute
Paese: Germania


Werner Baumann (CEO)
Wolfgang Nickl (CFO)
Oliver Maier (Head of Investor Relations)


Bayer is a diversified Life Sciences group structured in two core divisions: Healthcare & Crop Sciences. In Healthcare, Bayer has a diversified portfolio covering Pharmaceuticals (multiple sclerosis, cardiology, ophthalmology, oncology) & Consumer Health. In Crop Science, Bayer is now the world's leading agriculture enterprise following its acquisition of Monsanto and is split broadly 60:40 in Healthcare and Crop. Bayer continues to narrow its focus, achieving a full exit from Covestro (Material Sciences) in 2018, divesting several consumer assets (Coppertone, Dr. Scholls) and its Currenta (Chemicals) stake in 2019, and announcing the sale of its Animal Health business to Elanco.

Informazioni di mercato

Prezzo 57,0 EUR      
Scaricare in formato Excel

Fonte: Exane Derivatives, 14/08/2020
I prezzi indicati sono prezzi MID.
Le performance passate non sono un indicatore delle performance future.
I calcoli sono stati realizzati in buona fede a titolo esclusivamente informativo.
Informazioni legali.